Novel strategies of regenerative medicine using chemical compounds

Current Medicinal Chemistry

Volumn 17, Issue 34, 2010, Pages 4134-4149

  Lasagni, L ^a   Sagrinati, C ^a   Ronconi, E ^a   Angelotti, M L ^a   Parente, E ^a   Ballerini, L ^a   Peired, A ^a   Romagnani, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Hh; Ips cells; Notch; Ras; Stem cell; Wnt

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; 2 CHLORO N [4 CHLORO 3 (2 PYRIDINYL)PHENYL] 4 METHANESULFONYLBENZAMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 7 [N [N (3,5 DIFLUOROPHENYL) 1 ALANYL]] S PHENYL GLYCINE TERT BUTYL ESTER; [3 [[6 (3 AMINOPHENYL) 1H PYRROLO[2,3 D]PYRIMIDIN 4 YL]OXY]PHENOL]; AZACITIDINE; CHIR 99021; CONOPHYLLINE; CYCLOPAMINE; DIBENZAZEPINE DERIVATIVE; GAMMA SECRETASE INHIBITOR; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; KENPAULLONE; MITOGEN ACTIVATED PROTEIN KINASE; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; N2 [2 (3,5 DIFLUOROPHENYL) 2 HYDROXYACETYL] N1 (6,7 DIHYDRO 5 METHYL 6 OXO 5H DIBENZ[B,D]AZEPIN 7 YL)ALANINAMIDE; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLURIPOTIN; PROTEIN KINASE B; PURMORPHAMINE; RAS PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TWS 119; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VANADIUM DERIVATIVE; VORINOSTAT; WNT PROTEIN;

ADIPOGENESIS; ADULT STEM CELL; ARTICLE; CELL DIFFERENTIATION; CELL HOMING; CELL RENEWAL; CELL SURVIVAL; COLORECTAL CANCER; DRUG ACTIVITY; EMBRYO CELL; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PANCREAS ADENOCARCINOMA; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; SOMATIC CELL; STEM CELL TRANSPLANTATION;

ADULT; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; MICE; ORGANIC CHEMICALS; RATS; REGENERATION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STEM CELL NICHE; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 78650643454     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710793348590     Document Type: Article

References (100)

1. Blanpain, C.; Horsley, V.; Fuchs, E. Epithelial stem cells: turning over new leaves. Cell, 2007, 128, 445-58.
2. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282, 1145-47.
3. Bhattacharya, N. fetal cell/tissue therapy in adult disease: a new horizon in regenerative medicine. Clin. Exp. Obstet. Gynecol., 2004, 31, 167-73.
4. Sagrinati, C.; Ronconi, E.; Lazzeri, E.; Lasagni, L.; Romagnani, P. Stem-cell approaches for kidney repair: choosing the right cells. Trends Mol. Med., 2008, 14, 277-85.
5. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126, 663-76.
6. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 131, 861-72.
7. Boyer, L. A.; Lee, T. I.; Cole, M. F.; Johnstone, S. E.; Levine, S. S.; Zucker, J. P.; Guenther, M. G.; Kumar, R. M.; Murray, H. L.; Jenner, R. G.; Gifford, D. K.; Melton, D. A.; Jaenisch, R.; Young, R. A. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell, 2005, 122, 947-56.
8. Mikkelsen, T. S.; Ku, M.; Jaffe, D. B.; Issac, B.; Lieberman, E.; Giannoukos, G.; Alvarez, P.; Brockman, W.; Kim, T. K.; Koche, R. P.; Lee, W.; Mendenhall, E.; O'Donovan, A.; Presser, A.; Russ, C.; Xie, X.; Meissner, A.; Wernig, M.; Jaenisch, R.; Nusbaum, C.; Lander, E. S.; Bernstein, B. E. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature, 2007, 448, 553-60.
9. Scadden, D. T. The stem-cell niche as an entity of action. Nature, 2006, 441, 1075-79.
10. Romagnani, P.; Lasagni, L.; Mazzinghi, B.; Lazzeri, E.; Romagnani, S. Pharmacological modulation of stem cell function. Curr. Med. Chem., 2007, 14, 1129-39.
11. van Es, J. H.; Jay, P.; Gregorieff, A.; van Gijn, M. E.; Jonkheer, S.; Hatzis, P.; Thiele, A.; van den Born, M.; Begthel, H.; Brabletz, T.; Taketo, M. M.; Clevers, H. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat. Cell Biol., 2005, 7, 381-86.
12. Pinto, D.; Gregorieff, A.; Begthel, H.; Clevers, H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev., 2003, 17, 1709-13.
13. Reya, T.; Clevers, H. Wnt signalling in stem cells and cancer. Nature, 2005, 432, 843-50. (Pubitemid 40558990)
14. Malhotra, S.; Kincade, P. W. Wnt-related molecules and signalling pathway equilibrium in hematopoiesis. Cell Stem Cell, 2009, 4, 27-36.
15. Blanpain, C.; Fuchs, E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat. Rev. Mol. Cell. Biol., 2009, 10, 207-217.
16. Otto, A.; Schmidt, C.; Luke, G.; Allen, S.; Valasek, P.; Muntoni, F.; Lawrence-Watt, D.; Patel, K. Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration. J. Cell Sci., 2008, 121, 2939-50.
17. Otto, A.; Schmidt, C.; Luke, G.; Allen, S.; Valasek, P.; Muntoni, F.; Lawrence-Watt, D.; Patel, K. Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration. J. Cell Sci., 2008, 121, 2939-50.
18. Adachi, K.; Mirzadesh, Z.; Sakaguchi, M.; Yamashita, T.; Nikolcheva, T.; Gotoh, Y.; Peltz, G.; Gong, L.; Kawase, T.; Alvarez-Buylla, A.; Okano, H.; Sawamoto, K. Beta-catenin signalling promotes proliferation of progenitor cells in the adult mouse subventricular zone. Stem Cells 2007, 25, 2827-36.
19. Hirabayashi, Y.; Itoh, Y.; Tabata, H.; Nakajima, K.; Akiyama, T.; Masuyama, N.; Gotoh, Y. The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells. Development, 2004, 131, 2791-2801.
20. Gao, C.; Chen, Y. C. Dishevelled: the hub of Wnt signalling. Cell Signal., 2010, 22, 717-27.
21. Coghlan, M. P.; Culbert, A. A.; Cross, D. A.; Corcoran, S. L.; Yates, J. W.; Pearce, N. J.; Rausch, O. L.; Murphy, G. J.; Carter, P. S.; Roxbee Cox, L.; Mills, D.; Brown, M. J.; Haigh, D.; Ward, R. W.; Smith, D. G.; Murray, K. J.; Reith, A. D.; Holder, J. C. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol., 2000, 7, 793-803.
22. Maurer, M. H.; Brömme, J. O.; Feldmann, R. E. Jr.; Järve, A.; Sabouri, F.; Bürgers, H. F.; Schelshorn, D. W.; Krüger, C.; Schneider, A.; Kuschinsky, W. Glycogen synthase kinase 3beta (GSK3beta) regulates differentiation and proliferation in neural stem cells from the rat subventricular zone. J. Proteome Res., 2007, 6, 1198-208.
23. Korur S, Huber RM, Sivasankaran B, Petrich M, Morin P Jr, Hemmings BA, Merlo A, Lino MM. GSK3beta regulates differentiation and growth arrest in glioblastoma PLoS One. 2009;4: e7443
24. Inoue, T.; Kagawa, T.; Fukushima, M.; Shimizu, T.; Yoshinaga, Y.; Takada, S.; Tanihara, H.; Taga, T. Activation of canonical Wnt pathway promotes proliferation of retinal stem cells derived from adult mouse ciliary margin. Stem Cells, 2006, 24, 95-104.
25. Osakada, F.; Ooto, S.; Akagi, T.; Mandai, M.; Akaike, A.; Takahashi, M. Wnt signaling promotes regeneration in the retina of adult mammals. J Neurosci., 2007, 27, 4210-4219.
26. Kubo, F.; Takeichi, M.; Nakagawa, S. Wnt2b controls retinal cell differentiation at the ciliary marginal zone. Development, 2003, 130, 587-598.
27. Kubo, F.; Takeichi, M.; Nakagawa, S. Wnt2b inhibits differentiation of retinal progenitor cells in the absence of Notch activity by downregulating the expression of proneural genes. Development, 2005, 132, 2759-2770.
28. Cho, S. H.; Cepko, C. L. Wnt2b/b-catenin-mediated canonical Wnt signaling determines the peripheral fates of the chick eye. Development, 2006, 133, 3167-77.
29. Sato, N.; Meijer, L.; Skaltsounis. L.; Greengard, P.; Brivanlou, A. H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med., 2004, 10, 55-63.
30. Filipczyk, A. A.; Passier, R.; Rochat, A.; Mummery, C. L. Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling. Cell Mol. Life Sci., 2007, 64, 704-18.
31. Ullmann, U.; Gilles, C.; De Rycke, M.; Van de Velde, H.; Sermon, K.; Liebaers, I. GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions. Mol. Hum. Reprod., 2008, 14, 169-79.
32. Zaragosi, L. E.; Wdziekonski, B.; Fontaine, C.; Villageois, P.; Peraldi, P.; Dani, C. Effects of GSK3 inhibitors on in vitro expansion and differentiation of human adipose-derived stem cells into adipocytes. BMC Cell Biol., 2008, 9, 11.
33. Tateishi, K.; Ashihara, E.; Honsho, S.; Takehara, N.; Nomura, T.; Takahashi, T.; Ueyama T.; Yamagishi, M.; Yaku, H.; Matsubara, H.; Oh, H. Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signaling. Biochem. Biophys. Res. Commun., 2007, 352, 635-41.
34. Ding, S.; Wu, T. Y.; Brinker, A.; Peters, E. C.; Hur, W.; Gray, N. S.; Schultz, P. G. Synthetic small molecules that control stem cell fate. Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 7632-7.
35. Kordes, C.; Sawitza, I.; Häussinger, D. Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells. Biochem. Biophys. Res. Commun., 2008, 367, 116-23.
36. Bennett, C. N.; Ross, S. E.; Longo, K. A.; Bajnok, L.; Hemati, N.; Johnson, K. W.; Harrison, S. D.; MacDougald, O. A. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem., 2002, 27, 30998-1004.
37. Ying, Q. L.; Wray, J.; Nichols, J.; Batlle-Morera, L.; Doble, B.; Woodgett, J.; Cohen, P.; Smith, A. The ground state of embryonic stem cell self-renewal. Nature, 2008, 453, 519-23.
38. Trowbridge J. J.; Xenocostas, A.; Moon, R. T.; Bhatia, M. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nature Medicine, 2005, 12, 89-98.
39. Castelo-Branco, G.; Rawal, N.; Arenas, E. GSK-3beta inhibition/beta- catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J. Cell Sci., 2004, 117, 5731-7.
40. Artavanis-Tsakonas, S.; Rand, M. D.; Lake, R. J. Notch signaling: cell fate control and signal integration in development. Science, 1999, 284, 770-6.
41. Jensen, J.; Pedersen, E. E.; Galante, P.; Hald, J.; Heller, R. S.; Ishibashi, M.; Kageyama, R.; Guillemot, F.; Serup, P.; Madsen, O. D. Control of endodermal endocrine development by Hes-1. Nat. Genet., 2000, 24, 36-44.
42. Stanger, B. Z.; Datar, R.; Murtaugh, L. C.; Melton, D. A. Direct regulation of intestinal fate by Notch. Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 12443-8.
43. Moriyama, M.; Durham, A. D.; Moriyama, H.; Hasegawa, K.; Nishikawa, S.; Radtke, F.; Osawa, M. Multiple roles of Notch signaling in the regulation of epidermal development. Dev. Cell., 2008, 14, 594-604.
44. Pierfelice, T. J.; Schreck, K. C.; Eberhart, C. G.; Gaiano, N. Notch, neural stem cells, and brain tumors. Cold Spring Harb. Symp. Quant. Biol., 2008, 73, 367-75.
45. Duncan, A. W.; Rattis, F. M.; DiMascio, L. N.; Kongdon, K. L.; Pazianos, G.; Zhao, C.; Yoon, K.; Cook, J. M.; Willert, K.; Gaiano, N.; Reya, T. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat. Immunol., 2005, 6, 314-22. (Pubitemid 41724769)
46. Vujovic, S.; Henderson, S. R.; Flanagan, A. M.; Clements, M. O. Inhibition of gamma-secretases alters both proliferation and differentiation of mesenchymal stem cells. Cell Prolif., 2007, 40, 185-95.
47. Woo, S. M.; Kim, J.; Han, H. W.; Chae, J. I.; Son, M. Y.; Cho, S.; Chung, H. M.; Han, Y. M.; Kang, Y. K. Notch signaling is required for maintaining stem-cell features of neuroprogenitor cells derived from human embryonic stem cells. BMC Neurosci., 2009, 10, 97.
48. Wang, L.; Chopp, M.; Zhang, R. L.; Zhang, L.; Letourneau, Y.; Feng, Y. F.; Jiang, A.; Morris, D. C.; Zhang, Z. G. The Notch pathway mediates expansion of a progenitor pool and neuronal differentiation in adult neural progenitor cells after stroke. Neuroscience, 2009, 158, 1356-63.
49. Hayes, S.; Nelson, B. R.; Buckingham, B.; Reh, T. A. Notch signaling regulates regeneration in the avian retina. Dev. Biol., 2007, 312, 300-11.
50. Kitzmann, M.; Bonnieu, A.; Duret, C.; Vernus, B.; Barro, M.; Laoudj-Chenivesse, D.; Verdi, J. M.; Carnac, G. Inhibition of Notch signaling induces myotube hypertrophy by recruiting a subpopulation of reserve cells. J. Cell Physiol., 2006, 208, 538-48.
51. De Smedt, M.; Hoebeke, I.; Reynvoet, K.; Leclercq, G.; Plum, J. Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic-, or T-cell lineage in thymus microenvironment. Blood, 2005, 106, 3498-506.
52. Wong, G. T.; Manfra, D.; Poulet, F. M.; Zhang, Q.; Josien, H.; Bara, T.; Engstrom, L.; Pinzon-Ortiz, M.; Fine, J. S.; Lee, H. J.; Zhang, L.; Higgins, G. A.; Parker, E. M. Chronic treatment with the gammasecretase inhibitor LY-411, 575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J. Biol. Chem., 2004, 279, 12876-82.
53. Okamoto, R.; Tsuchiya, K.; Nemoto, Y.; Akiyama, J.; Nakamura, T.; Kanai, T.; Watanabe, M. Requirement of Notch activation during regeneration of the intestinal epithelia. Am. J. Physiol. Gastrointest. Liver Physiol., 2009, 296, G23-G35.
54. Croquelois, A.; Domenighetti, A. A.; Nemir, M.; Lepore, M.; Rosenblatt-Velin, N.; Radtke, F.; Pedrazzini, T. Control of the adaptive response of the heart to stress via the Notch1 receptor pathway. J. Exp. Med., 2008, 205, 3173-85.
55. van Hes, J. H.; van Gijn, M. E.; Riccio, O.; van der Born, M.; Vooijs, M.; Begthel, H.; Cozijnsen, M.; Robine, S.; Winton, D. J.; Radtke, F.; Clevers, H. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature, 2005, 435, 959-963.
56. van Hes, J. H.; Clevers, H. Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease. Trends Mol. Med., 2005, 11, 496-502.
57. Cohen, M. M. Jr. The hedgehog signaling network. Am. J. Med. Genet. A., 2003, 123 A, 5-28.
58. Kawahira, H.; Scheel, D. W.; Smith, S. B.; German, M. S.; Hebrok, M. Hedgehog signaling regulates expansion of pancreatic epithelial cells. Dev. Biol., 2005, 280, 111-21.
59. D'Amour, K. A.; Bang, A. G.; Eliazer, S.; Kelly, O. G.; Agulnick, A. D.; Smart, N. G.; Moorman, M. A.; Kroon, E.; Carpenter, M. K.; Baetge, E. E. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol., 2006, 24, 1392-401.
60. Ogata, T.; Li, L.; Yamada, S.; Yamamoto, Y.; Tanaka, Y.; Takei, I.; Umezawa, K.; Kojima, I. Promotion of beta-cell differentiation by conophylline in fetal and neonatal rat pancreas. Diabetes, 2004, 53, 2596-602.
61. Umezawa, K.; Hiroki, A.; Kawakami, M.; Naka, H.; Takei, I.; Ogata, T.; Kojima, I.; Koyano, T.; Kowithayakorn, T.; Pang, H. S.; Kam, T. S. Induction of insulin production in rat pancreatic acinar carcinoma cells by conophylline. Biomed. Pharmacother., 2003, 57, 341-50.
62. Tourrel, C.; Bailbé, D.; Meile, M. J.; Kergoat, M.; Portha, B. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes, 2001, 50, 1562-70.
63. Trowbridge, J. J.; Scott, M. P.; Bhatia, M. Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 14134-9.
64. Gering, M.; Patient, R. Hedgehog signaling is required for adult blood stem cell formation in zebrafish embryos. Dev. Cell, 2005, 8, 389-400.
65. Kobune, M.; Kato, J.; Kawano, Y.; Sasaki, K.; Uchida, H.; Takada, K.; Takahashi, S.; Takimoto, R.; Niitsu, Y. Adenoviral vectormediated transfer of the Indian hedgehog gene modulates lymphomyelopoiesis in vivo. Stem Cells, 2008, 26, 534-42.
66. Ahn, S.; Joyner, A. L. In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog. Nature, 2005, 437, 894-7.
67. Palma, V.; Lim, D. A.; Dahmane, N.; Sánchez, P.; Brionne, T. C.; Herzberg, C. D.; Gitton, Y.; Carleton, A.; Alvarez-Buylla, A.; Ruizi Altaba, A. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain. Development, 2005, 132, 335-44.
68. Gaspard, N.; Bouschet, T.; Herpoel, A.; Naeije, G.; van den Ameele, J.; Vanderhaeghen, P. Generation of cortical neurons from mouse embryonic stem cells. Nat. Protoc., 2009, 4, 1454-63.
69. Hu, B. Y.; Zhang, S. C. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat. Protoc., 2009, 4, 1295-304.
70. Li, X. J.; Hu, B. Y.; Jones, S. A.; Zhang, Y. S.; Lavaute, T.; Du, Z. W.; Zhang, S. C. Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells, 2008, 26, 886-93.
71. Clement, C. A.; Kristensen, S. G.; Møllgård, K.; Pazour, G. J.; Yoder, B. K.; Larsen, L. A.; Christensen, S. T. The primary cilium coordinates early cardiogenesis and hedgehog signaling in cardiomyocyte differentiation. J. Cell Sci., 2009, 122, 3070-82.
72. Kang, D. H.; Han, M. E.; Song, M. H.; Lee, Y. S.; Kim, E. H.; Kim, H. J.; Kim, G. H.; Kim, D. H.; Yoon, S.; Baek, S. Y.; Kim, B. S.; Kim, J. B.; Oh, S. O. The role of hedgehog signaling during gastric regeneration. J. Gastroenterol., 2009, 44, 372-9.
73. Wu, X.; Walker, J.; Zhang, J.; Ding, S.; Schultz, P. G. Purmorphamine Induces Osteogenesis by Activation of the Hedgehog Signaling Pathway. Chem. Biol., 2004, 11, 1229-38.
74. Plaisant, M.; Fontaine, C.; Cousin, W.; Rochet, N.; Dani, C.; Peraldi, P. Activation of hedgehog signaling inhibits osteoblast differentiation of human mesenchymal stem cells. Stem Cells, 2009, 27, 703-13.
75. Wu, X.; Ding, S.; Ding, Q.; Gray, N. S.; Schultz, P. G. A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells. J. Am. Chem. Soc., 2002, 124, 14520-1.
76. Fontaine, C.; Cousin, W.; Plaisant, M.; Dani, C.; Peraldi, P. Hedgehog signaling alters adipocyte maturation of human mesenchymal stem cells. Stem Cells, 2008, 26, 1037-46.
77. Das, A. V.; Bhattacharya, S.; Zhao, X.; Hegde, G.; Mallya, K.; Eudy, J. D.; Ahmad, I. The canonical Wnt pathway regulates retinal stem cells/progenitors in concert with Notch signaling. Dev. Neurosci., 2008, 30, 389-409.
78. Kubo, F.; Nakagawa, S. Hairy1 acts as a node downstream of Wnt signaling to maintain retinal stem cell-like progenitor cells in the chick ciliary marginal zone. Development, 2009, 136, 1823-33.
79. Katoh, M.; Katoh, M. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int. J. Mol. Med., 2006, 17, 681-5.
80. Shimizu, T.; Kagawa, T.; Inoue, T.; Nonaka, A.; Takada, S.; Aburatani, H.; Taga, T. Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells. Mol. Cell. Biol., 2008, 28, 7427-7441.
81. Wall, D. S.; Mears, A. J.; McNeill, B.; Mazerolle, C.; Thurig, S.; Wang, Y.; Kageyama, R.; Wallace, V. A. Progenitor cell proliferation in the retina is dependent on Notch-independent Sonic hedgehog/Hes1 activity. J. Cell Biol., 2009, 184, 101-112.
82. Ingram, W. J.; McCue, K. I.; Tran, T. H.; Hallahan, K. R.; Wainwright B. J. Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling. Oncogene, 2008, 27, 1489-1500.
83. Nakamura, T.; Tsuchiya, K.; Watanabe, M. Crosstalk between Wnt and Notch signaling in intestinal epithelial cell fate decision. J. Gastroenterol., 2007, 42, 705-10.
84. Chen, S.; Do, J. T.; Zhang, Q.; Yao, S.; Yan, F.; Peters, E. C.; Schöler, H. R.; Schultz, P. G.; Ding, S. Self-renewal of embryonic stem cells by a small molecule. Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 17266-71.
85. Xiong, W.; Gao, Y.; Cheng, X.; Martin, C.; Wu, D.; Yao, S.; Kim, M. J.; Liu, Y. The use of SC1 (Pluripotin) to support mESC selfrenewal in the absence of LIF. J. Vis. Exp., 2009, pii: 1550 doi: 10.3791/1550.
86. Shioda, N.; Han, F.; Morioka, M.; Fukunaga, K. Bis (1-oxy-2- pyridinethiolato) oxovanadium (IV) enhances neurogenesis via phosphatidylinositol 3-kinase/Akt and extracellular signal regulated kinase activation in the hippocampal subgranular zone after mouse focal cerebral ischemia. Neuroscience, 2008, 155, 876-87.
87. Ptasznik, A.; Beattie, G. M.; Mally, M. I.; Cirulli, V.; Lopez, A.; Hayek, A. Phosphatidylinositol 3-kinase is a negative regulator of cellular differentiation. J. Cell Biol., 1997, 137, 1127-36.
88. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126, 663-76.
89. Lowry, W. E.; Richter, L.; Yachechko, R.; Pyle, A. D.; Tchieu, J.; Sridharan, R.; Clark, A. T.; Plath, K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 2883-8.
90. Kim, J. B.; Sebastiano, V.; Wu, G.; Araúzo-Bravo, M. J.; Sasse, P.; Gentile, L.; Ko, K.; Ruau, D.; Ehrich, M.; van den Boom, D.; Meyer, J.; Hübner, K.; Bernemann, C.; Ortmeier, C.; Zenke, M.; Fleischmann, B. K.; Zaehres, H.; Schöler, H. R. Oct4-induced pluripotency in adult neural stem cells. Cell, 2009, 136, 411-9.
91. Mikkelsen, T. S.; Hanna, J.; Zhang, X.; Ku, M.; Wernig, M.; Schorderet, P.; Bernstein, B. E.; Jaenisch, R.; Lander, E. S.; Meissner, A. Dissecting direct reprogramming through integrative genomic analysis. Nature, 2008, 454, 49-55.
92. Huangfu, D.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Snitow, M.; Chen, A. E.; Melton, D. A. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol., 2008, 26, 795-7.
93. Feng, B.; Ng, J. H.; Heng, J. C.; Ng, H. H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell, 2009, 4, 301-12.
94. Huangfu, D.; Osafune, K.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Chen, S.; Muhlestein, W.; Melton, D. A. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol., 2008, 26, 1269-75.
95. Feldman, N.; Gerson, A.; Fang, J.; Li, E.; Zhang, Y.; Shinkai, Y.; Cedar, H.; Bergman, Y. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol., 2006, 8, 188-94.
96. Epsztejn-Litman, S.; Feldman, N.; Abu-Remaileh, M.; Shufaro, Y.; Gerson, A.; Ueda, J.; Deplus, R.; Fuks, F.; Shinkai, Y.; Cedar, H.; Bergman, Y. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat. Struct. Mol. Biol., 2008, 15, 1176-83.
97. Shi, Y.; Do, J. T.; Desponts, C.; Hahm, H. S.; Schöler, H. R.; Ding, S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell, 2008, 2, 525-8.
98. Shi, Y.; Desponts, C.; Do, J. T.; Hahm, H. S.; Schöler, H. R.; Ding, S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell, 2008, 3, 568-74.
99. Silva, J.; Barrandon, O.; Nichols, J.; Kawaguchi, J.; Theunissen, T. W.; Smith, A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol., 2008, 6, e253.
100. Lyssiotis, C. A.; Foreman, R. K.; Staerk, J.; Garcia, M.; Mathur, D.; Markoulaki, S.; Hanna, J.; Lairson, L. L.; Charette, B. D.; Bouchez, L. C.; Bollong, M.; Kunick, C.; Brinker, A.; Cho, C. Y.; Schultz, P. G.; Jaenisch, R. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 8912-17.